Ted W. Love
2020
In 2020, Ted W. Love earned a total compensation of $17.6M as President, Chief Executive Officer and Director at Global Blood Therapeutics, a 74% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $467,000 |
|---|---|
| Option Awards | $4,693,666 |
| Salary | $661,250 |
| Stock Awards | $11,778,840 |
| Other | $5,000 |
| Total | $17,605,756 |
Love received $11.8M in stock awards, accounting for 67% of the total pay in 2020.
Love also received $467K in non-equity incentive plan, $4.7M in option awards, $661.3K in salary and $5K in other compensation.
Rankings
In 2020, Ted W. Love's compensation ranked 284th out of 13,090 executives tracked by ExecPay. In other words, Love earned more than 97.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 284 out of 13,090 | 98th |
Division Manufacturing | 92 out of 5,621 | 98th |
Major group Chemicals And Allied Products | 30 out of 2,254 | 99th |
Industry group Drugs | 27 out of 1,954 | 99th |
Industry Pharmaceutical Preparations | 18 out of 1,459 | 99th |
Pay ratio
| Ted W. Love's Pay | $17,605,756 |
|---|---|
| Median Employee's Pay | $373,366 |
| Pay Ratio | 47to 1 |
In 2020, the annual total compensation of Ted W. Love was $17,605,756.
The annual total compensation of the median employee at Global Blood Therapeutics was $373,366.
The ratio of Ted W. Love's pay to the pay of median employee was therefore 47 to one.
Source: SEC filing on April 28, 2021.
Love's colleagues
We found four more compensation records of executives who worked with Ted W. Love at Global Blood Therapeutics in 2020.